Skip to content

Preoperative Ventricular Tachycardia and Postoperative Outcomes in Hypertrophic Obstructive Cardiomyopathy: A Prospective Observational Study

Preoperative Ventricular Tachycardia and Postoperative Outcomes in Hypertrophic Obstructive Cardiomyopathy: A Prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114711
Enrollment
Unknown
Registered
2025-12-17
Start date
2025-12-18
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic Obstructive Cardiomyopathy

Interventions

Sponsors

General Hospital of Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Diagnosed with drug-refractory hypertrophic obstructive cardiomyopathy. 2)Scheduled to undergo the modified Morrow procedure. 3)Availability of pre-operative cardiac ultrasound (echocardiography) images. 4)Age >= 14 and <= 80 years.

Exclusion criteria

Exclusion criteria: 1)Presence of any surgical contraindications (e.g., uncontrolled infection, irreversible severe pulmonary hypertension, etc.). 2)Pre-operative left ventricular ejection fraction (LVEF) < 0.3. 3)Previous history of Morrow procedure. 4)Poor-quality pre-operative echocardiographic images that preclude accurate assessment of the left ventricular outflow tract pressure gradient. 5)Concurrent acute myocardial infarction with onset within less than 7 days. 6)Comorbid with severe hepatic, renal, or pulmonary failure, or any other disease with a life expectancy of < 1 year. 7)Requirement for concomitant other complex cardiac surgical procedures.

Design outcomes

Primary

MeasureTime frame
The rate of left ventricular outflow tract pressure gradient reaching the standard half a year after operation;

Secondary

MeasureTime frame
Major adverse cardiac events occurred within 6 months after the procedure;LVOT gradient at 72 hours after surgery and its change from baseline;Interventricular septal thickness at 6 months after surgery;Left atrial diameter;Left ventricular ejection fraction (LVEF);The NYHA cardiac function classification was evaluated at 6 months after operation;A permanent pacemaker was implanted;A second thoracotomy was performed to stop bleeding;The actual weight of myocardial resection during operation;Cardiopulmonary bypass time;Aortic cross-clamp time;Length of ICU stay;The total length of postoperative hospital stay;

Countries

China

Contacts

Public ContactYin Zongtao

General Hospital of Northern Theater Command

yzt711210@sina.com+86 133 0988 1423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026